In infant reflux, when is a 4-week trial of acid-suppressing medication appropriate?

In infant reflux, when is a 4-week trial of acid-suppressing medication appropriate?

• A. After failure of thickening
• B. Always for all infants
• C. When the infant is not growing well or appears to be in pain
• D. Only if formula intolerance

Answer: (C)

In infant reflux, most regurgitation is physiologic and doesn’t require acid-suppressing meds. A four-week trial of acid suppression is appropriate only when there are red flags suggesting more than simple reflux, specifically poor growth or the infant appears to be in pain with feeds. Before starting, use conservative steps like appropriate feeding changes and thickening if needed, smaller, more frequent feeds, and ensuring the infant isn’t overfed. If the infant shows poor weight gain or ongoing distress despite these measures, a limited four-week trial can be considered. If there is improvement in growth and comfort, continue with careful follow-up and plan to reassess later; if there’s no improvement or adverse effects occur, stop and reevaluate for other causes such as intolerance, esophagitis, or other conditions.

In infant reflux, most regurgitation is physiologic and doesn’t require acid-suppressing meds. A four-week trial of acid suppression is appropriate only when there are red flags suggesting more than simple reflux, specifically poor growth or the infant appears to be in pain with feeds. Before starting, use conservative steps like appropriate feeding changes and thickening if needed, smaller, more frequent feeds, and ensuring the infant isn’t overfed. If the infant shows poor weight gain or ongoing distress despite these measures, a limited four-week trial can be considered. If there is improvement in growth and comfort, continue with careful follow-up and plan to reassess later; if there’s no improvement or adverse effects occur, stop and reevaluate for other causes such as intolerance, esophagitis, or other conditions.